Drug
Tax2
Tax2: highest development phase Phase 1/2, developed by Apmonia Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Apmonia Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| TAX2 NCT07688148 | Phase 1/2 | Solid Tumor Cancers |
Latest
No recent events.
Follow Tax2 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.